Norges Bank Vertex Pharmaceuticals Inc Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

49 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$392.81 - $485.53 $1.35 Billion - $1.66 Billion
3,429,086 New
3,429,086 $1.61 Billion
Q4 2023

Feb 09, 2024
BUY
$343.0 - $410.68 $1.04 Billion - $1.25 Billion
3,042,288 New
3,042,288 $1.24 Billion
Q3 2023

Nov 13, 2024
BUY
$338.18 - $362.46 $904 Million - $969 Million
2,673,906 New
2,673,906 $930 Million
Q3 2023

Nov 13, 2023
SELL
$338.18 - $362.46 $774 Million - $829 Million
-2,288,472 Closed
0 $0
Q2 2023

Aug 14, 2024
SELL
$314.42 - $351.91 $258 Million - $289 Million
-820,175 Reduced 23.92%
2,608,911 $918 Million
Q2 2023

Aug 14, 2023
SELL
$314.42 - $351.91 $700 Million - $784 Million
-2,226,598 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$283.23 - $323.1 $716 Million - $817 Million
2,528,939 New
2,528,939 $797 Million
Q4 2022

Feb 14, 2023
BUY
$285.76 - $321.48 $701 Million - $788 Million
2,451,521 New
2,451,521 $708 Million
Q3 2022

Nov 13, 2023
BUY
$273.83 - $305.53 $627 Million - $699 Million
2,288,472 New
2,288,472 $663 Million
Q2 2022

Aug 14, 2023
BUY
$234.96 - $292.55 $523 Million - $651 Million
2,226,598 New
2,226,598 $627 Million
Q1 2022

May 12, 2023
BUY
$221.42 - $260.97 $38.4 Million - $45.2 Million
173,227 Added 7.07%
2,624,748 $685 Million
Q1 2022

May 09, 2022
SELL
$221.42 - $260.97 $593 Million - $699 Million
-2,679,899 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$177.01 - $223.45 $474 Million - $599 Million
2,679,899 New
2,679,899 $589 Million
Q3 2021

Nov 14, 2022
BUY
$181.39 - $202.99 $458 Million - $513 Million
2,526,180 New
2,526,180 $458 Million
Q3 2021

Nov 05, 2021
SELL
$181.39 - $202.99 $462 Million - $517 Million
-2,547,430 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$187.49 - $221.1 $478 Million - $563 Million
2,547,430 New
2,547,430 $514 Million
Q2 2021

Aug 10, 2021
SELL
$187.49 - $221.1 $495 Million - $583 Million
-2,637,526 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$207.02 - $241.31 $546 Million - $636 Million
2,637,526 New
2,637,526 $567 Million
Q1 2021

May 07, 2021
SELL
$207.02 - $241.31 $574 Million - $669 Million
-2,771,326 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$207.01 - $276.09 $574 Million - $765 Million
2,771,326 New
2,771,326 $655 Million
Q4 2020

Feb 10, 2021
SELL
$207.01 - $276.09 $593 Million - $790 Million
-2,862,254 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$255.65 - $303.1 $732 Million - $868 Million
2,862,254 New
2,862,254 $779 Million
Q3 2020

Nov 10, 2020
SELL
$255.65 - $303.1 $687 Million - $814 Million
-2,686,403 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$225.48 - $295.8 $606 Million - $795 Million
2,686,403 New
2,686,403 $780 Million
Q2 2020

Aug 07, 2020
SELL
$225.48 - $295.8 $572 Million - $751 Million
-2,537,913 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$199.77 - $247.81 $507 Million - $629 Million
2,537,913 New
2,537,913 $604 Million
Q1 2020

May 08, 2020
SELL
$199.77 - $247.81 $503 Million - $624 Million
-2,517,603 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$166.71 - $223.91 $420 Million - $564 Million
2,517,603 New
2,517,603 $551 Million
Q4 2019

Feb 12, 2020
SELL
$166.71 - $223.91 $397 Million - $533 Million
-2,382,379 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$166.23 - $187.09 $396 Million - $446 Million
2,382,379 New
2,382,379 $404 Million
Q3 2019

Nov 08, 2019
SELL
$166.23 - $187.09 $396 Million - $446 Million
-2,382,379 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$164.61 - $190.37 $392 Million - $454 Million
2,382,379 New
2,382,379 $437 Million
Q2 2019

Aug 09, 2019
SELL
$164.61 - $190.37 $392 Million - $454 Million
-2,382,379 Closed
0 $0
Q1 2019

May 11, 2020
BUY
$163.73 - $194.7 $14 Million - $16.7 Million
85,698 Added 3.73%
2,382,379 $438 Million
Q4 2018

Mar 04, 2019
BUY
$151.91 - $192.21 $349 Million - $441 Million
2,296,681 New
2,296,681 $381 Million
Q4 2018

Feb 08, 2019
SELL
$151.91 - $192.21 $353 Million - $447 Million
-2,324,004 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$167.73 - $192.74 $390 Million - $448 Million
2,324,004 New
2,324,004 $448 Million
Q3 2018

Nov 09, 2018
SELL
$167.73 - $192.74 $397 Million - $456 Million
-2,365,207 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$145.72 - $169.96 $345 Million - $402 Million
2,365,207 New
2,365,207 $402 Million
Q2 2018

Jul 23, 2018
SELL
$145.72 - $169.96 $355 Million - $414 Million
-2,434,656 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$151.6 - $177.13 $369 Million - $431 Million
2,434,656 New
2,434,656 $397 Million
Q1 2018

May 09, 2018
SELL
$151.6 - $177.13 $355 Million - $415 Million
-2,340,504 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$137.28 - $155.55 $321 Million - $364 Million
2,340,504 New
2,340,504 $351 Million
Q4 2017

Feb 09, 2018
SELL
$137.28 - $155.55 $295 Million - $334 Million
-2,149,324 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$148.13 - $162.24 $318 Million - $349 Million
2,149,324 New
2,149,324 $327 Million
Q3 2017

Nov 07, 2017
SELL
$148.13 - $162.24 $300 Million - $328 Million
-2,024,052 Closed
0 $0
Q2 2017

Jul 24, 2018
SELL
N/A
-127,869 Reduced 5.94%
2,024,052 $261 Million
Q1 2017

May 11, 2018
BUY
N/A
476,868 Added 28.47%
2,151,921 $235 Million
Q3 2016

Nov 13, 2017
BUY
N/A
1,675,053
1,675,053 $0

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email